Free Trial
→ Free today: My 7-point options checklist (From Profits Run) (Ad)tc pixel Free AONCW Stock Alerts

American Oncology Network (AONCW) Competitors

$0.0006 0.00 (0.00%)
As of 06/12/2026
Compare

AONCW vs. AONC, NAKAW, PIIIW, TOIIW, and SXTPW

Should you buy American Oncology Network stock or one of its competitors? MarketBeat compares American Oncology Network with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with American Oncology Network include American Oncology Network (AONC), Kindly MD (NAKAW), P3 Health Partners (PIIIW), Oncology Institute (TOIIW), and 60 Degrees Pharmaceuticals (SXTPW). These companies are all part of the "medical" sector.

How does American Oncology Network compare to American Oncology Network?

American Oncology Network (OTCMKTS:AONC) and American Oncology Network (NASDAQ:AONCW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

Company Net Margins Return on Equity Return on Assets
American Oncology NetworkN/A N/A N/A
American Oncology Network N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Oncology Network$1.34BN/AN/AN/AN/A
American Oncology Network$1.34BN/AN/AN/AN/A

In the previous week, American Oncology Network had 4 more articles in the media than American Oncology Network. MarketBeat recorded 4 mentions for American Oncology Network and 0 mentions for American Oncology Network. American Oncology Network's average media sentiment score of 0.23 beat American Oncology Network's score of 0.00 indicating that American Oncology Network is being referred to more favorably in the media.

Company Overall Sentiment
American Oncology Network Neutral
American Oncology Network Neutral

Summary

American Oncology Network beats American Oncology Network on 2 of the 2 factors compared between the two stocks.

How does American Oncology Network compare to Kindly MD?

American Oncology Network (NASDAQ:AONCW) and Kindly MD (NASDAQ:NAKAW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

In the previous week, American Oncology Network's average media sentiment score of 0.00 equaled Kindly MD'saverage media sentiment score.

Company Overall Sentiment
American Oncology Network Neutral
Kindly MD Neutral

Company Net Margins Return on Equity Return on Assets
American Oncology NetworkN/A N/A N/A
Kindly MD N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Oncology Network$1.34BN/AN/AN/AN/A
Kindly MD$2.24MN/AN/AN/AN/A

Summary

American Oncology Network beats Kindly MD on 1 of the 1 factors compared between the two stocks.

How does American Oncology Network compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIIIW) and American Oncology Network (NASDAQ:AONCW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
P3 Health Partners$1.47BN/AN/AN/AN/A
American Oncology Network$1.34BN/AN/AN/AN/A

In the previous week, P3 Health Partners had 2 more articles in the media than American Oncology Network. MarketBeat recorded 2 mentions for P3 Health Partners and 0 mentions for American Oncology Network. P3 Health Partners' average media sentiment score of 0.43 beat American Oncology Network's score of 0.00 indicating that P3 Health Partners is being referred to more favorably in the media.

Company Overall Sentiment
P3 Health Partners Neutral
American Oncology Network Neutral

Company Net Margins Return on Equity Return on Assets
P3 Health PartnersN/A N/A N/A
American Oncology Network N/A N/A N/A

Summary

P3 Health Partners beats American Oncology Network on 3 of the 3 factors compared between the two stocks.

How does American Oncology Network compare to Oncology Institute?

American Oncology Network (NASDAQ:AONCW) and Oncology Institute (NASDAQ:TOIIW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Oncology Network$1.34BN/AN/AN/AN/A
Oncology Institute$545.76MN/AN/AN/AN/A

In the previous week, Oncology Institute had 1 more articles in the media than American Oncology Network. MarketBeat recorded 1 mentions for Oncology Institute and 0 mentions for American Oncology Network. Oncology Institute's average media sentiment score of 1.87 beat American Oncology Network's score of 0.00 indicating that Oncology Institute is being referred to more favorably in the news media.

Company Overall Sentiment
American Oncology Network Neutral
Oncology Institute Very Positive

Company Net Margins Return on Equity Return on Assets
American Oncology NetworkN/A N/A N/A
Oncology Institute N/A N/A N/A

Summary

Oncology Institute beats American Oncology Network on 2 of the 3 factors compared between the two stocks.

How does American Oncology Network compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and American Oncology Network (NASDAQ:AONCW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
American Oncology Network N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
American Oncology Network$1.34BN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than American Oncology Network. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for American Oncology Network. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat American Oncology Network's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
American Oncology Network Neutral

Summary

60 Degrees Pharmaceuticals beats American Oncology Network on 2 of the 3 factors compared between the two stocks.

Get American Oncology Network News Delivered to You Automatically

Sign up to receive the latest news and ratings for AONCW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AONCW vs. The Competition

Export
MetricAmerican Oncology NetworkMedical Care Facilities IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.70B$6.74B$12.07B
Dividend YieldN/A3.76%2.67%5.66%
P/E RatioN/A12.7123.9024.57
Price / SalesN/A18.22511.88141.49
Price / CashN/A7.9027.4837.92
Price / BookN/A1.7510.476.78
Net IncomeN/A$63.03M$3.56B$337.32M
7 Day PerformanceN/A0.38%0.66%2.20%
1 Month PerformanceN/A0.76%1.90%4.06%
1 Year PerformanceN/A10.76%24.86%29.91%

American Oncology Network Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AONCW
American Oncology Network
N/A$0.00
flat		N/AN/A$0.00$1.34BN/A1,525
AONC
American Oncology Network
N/A$12.00
+20.0%		N/AN/A$0.00$1.34BN/A1,520
NAKAW
Kindly MD
N/A$0.47
+3.3%		N/AN/A$0.00$2.24MN/A23
PIIIW
P3 Health Partners
N/A$0.02
-3.4%		N/A+55.2%$0.00$1.47BN/A500
TOIIW
Oncology Institute
N/A$0.05
+4.8%		N/A-22.2%$0.00$545.76MN/A660

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AONCW) was last updated on 6/16/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
The number nobody's bragging about
SPCX - the largest IPO in history - was predicted to open at $175. It opened at $150. Insiders bought in at a ...
Behind the Markets | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?
BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...
Awesomely, LLC | Sponsoredtc pixel